Evidence map›Paper›PMID 40627693›Full record

ArticleACS applied materials & interfaces2025

Chemochromic Damage-Detecting and Recovery System Using Affordable Hydrogel.

Hyun Jae Lee, Ryuma Niiyama

Abstract read
In one paragraph

Article in ACS applied materials & interfaces, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Hyun Jae LeeOrganization for the Strategic Coordination of Research and Intellectual Properties, Meiji University, Kawasaki, Kanagawa 214-8571, Japan.ORCID 0000-0002-2520-7433
Ryuma NiiyamaDepartment of Mechanical Engineering Informatics, School of Science and Technology, Meiji University, Kawasaki, Kanagawa 214-8571, Japan.ORCID 0000-0002-9072-8251

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A multipurpose chemochromic protector is proposed with a hydrogel made from a mixture of sodium chloride, starch, and water, and the deposition of a copper layer on the nylon polyethylene film surrounding the hydrogel. This hydrogel is found to be chemically stable, water-retaining, shock-absorbent, biocompatible, cost-effective, and highly reactive with copper enough to realize its chemochromic characteristics. The varying chemical compositions of the hydrogel show that the presence of poly(acrylic acid) (PAA) inside can enhance the damage-detecting and recovery capabilities of the protector. The compressive strength measurement reveals that the hydrogel becomes effectively solidified with the formation of copper chloride and the evaporation of water molecules to cover the damaged areas. In the shear strength experiment, the PAA-included hydrogel is proven to have the high adhesiveness necessary for the recovery of the protector. The damage-detecting and recovery experiment successfully presents the copper-specific chemochromic properties of the protector, implying that the addition of PAA intensifies the color changes of the hydrogel as well as its increased stiffness in the damaged areas. The chemochromically operating surface protector with a simple fabrication process, intuitive measurement, and an alternative working mechanism would be able to promote related studies and contribute to the development of additional protective measures such as for diverse protective clothing, miscellaneous robotic structures, and numerous space applications.

Indexed as

chemochromic sensingdamage detectiondamage recoveryhydrogelsodium chloridestarchsurface protection

Identifiers

PMID40627693
PMCPMC12291087

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.